Author = Akbar Oghalaei
Development and characterization of single domain monoclonal antibody against programmed cell death ligand-1; as a cancer inhibitor candidate

Volume 25, Issue 3, March 2022, Pages 313-319

10.22038/ijbms.2022.62522.13834

Akbar Oghalaei; Feriedon Mahbudi; Fatemeh Rahimi Jamnani; Somayeh Piri-Gavgani; Fatemeh Kazemi-Lomedasht; Aida Hassanzadeh-Eskafi; Delavar Shahbazzadeh; Ahmad Adeli; Yeganeh Talebkhan; Mahdi Behdani


In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin

Volume 25, Issue 1, January 2022, Pages 27-31

10.22038/ijbms.2021.54293.12195

Mohammad Hosseininejad-Chafi; Ehsan Alirahimi; Behzad Ramezani; Akbar Oghalaei; Nazli Sotoudeh; Hajarsadat Ghaderi; Fatemeh Kazemi-Lomedasht; Mahdi Habibi-Anbouhi; Reza Moazzami; Mahdi Behdani